Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    P1.06 - Poster Session 1 - Prognostic and Predictive Biomarkers

    • Type: Poster Session
    • Track: Biology
    • Presentations: 59
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.06-045 - Serum microRNA as a predictive marker for radiation pneumonitis in patients with inoperable/unresectablenon-small cell lung cancer (NSCLC)

      09:30 - 09:30  |  Author(s): N. Bi

      • Abstract

      Loading...

  • +

    P1.08 - Poster Session 1 - Radiotherapy

    • Type: Poster Session
    • Track: Radiation Oncology + Radiotherapy
    • Presentations: 27
    • Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P1.08-026 - Functional dosimetric metrics based on the ventilation and perfusion SPECT-CT during the course of radiotherapy and association with radiation-induced lung toxicity in patients with non-small-cell lung cancer

      09:30 - 09:30  |  Author(s): F. Peng

      • Abstract

      Loading...

  • +

    O01 - Prognostic and Predictive Biomarkers I

    • Type: Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 8
    • Moderators:T. Mitsudomi
    • Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
    • +

      O01.02 - MicroRNA Signature Predicts Survival in Resectable Small-Cell Lung Cancer

      10:40 - 10:50  |  Author(s): N. Bi

      • Abstract

      Loading...

  • +

    P3.06 - Poster Session 3 - Prognostic and Predictive Biomarkers

    • Type: Poster Session
    • Track: Biology
    • Presentations: 53
    • Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
    • +

      P3.06-041 - Serum miRNA signature predicts survival in patients with unresectable/inoperable non-small cell lung cancer treated with definitive radiation therapy

      09:30 - 09:30  |  Author(s): N. Bi

      • Abstract

      Loading...

  • +

    MO25 - NSCLC - Combined Modality Therapy II

    • Type: Mini Oral Abstract Session
    • Track: Mesothelioma
    • Presentations: 11
    • Moderators:T. Le Chevalier
    • Coordinates: 10/30/2013, 10:30 - 12:00, Parkside Ballroom B, Level 1
    • +

      MO25.10 - A Phase II trial of mid-treatment FDG-PET adaptive, individualized radiation therapy plus concurrent chemotherapy in patients with inoperable non-small cell lung cancer (NSCLC)

      11:25 - 11:30  |  Author(s): F.(. Kong

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.